Entera Bio 将来の成長
Future 基準チェック /06
Entera Bio's revenue and earnings are forecast to decline at 80.3% and 89.7% per annum respectively while EPS is expected to decline by 58.2% per annum.
主要情報
-89.7%
収益成長率
-58.2%
EPS成長率
| Biotechs 収益成長 | 27.1% |
| 収益成長率 | -80.3% |
| 将来の株主資本利益率 | n/a |
| アナリストカバレッジ | Low |
| 最終更新日 | 07 Oct 2024 |
今後の成長に関する最新情報
Recent updates
We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
Jul 12
Here's Why We're Not Too Worried About Entera Bio's (NASDAQ:ENTX) Cash Burn Situation
Mar 23We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
May 31Will Entera Bio (NASDAQ:ENTX) Spend Its Cash Wisely?
Feb 15Is Entera Bio (NASDAQ:ENTX) In A Good Position To Deliver On Growth Plans?
Oct 13Entera Bio GAAP EPS of -$0.24 , revenue of $0.11M
Aug 11We Think Entera Bio (NASDAQ:ENTX) Needs To Drive Business Growth Carefully
Jun 10Companies Like Entera Bio (NASDAQ:ENTX) Are In A Position To Invest In Growth
Jan 21We're Interested To See How Entera Bio (NASDAQ:ENTX) Uses Its Cash Hoard To Grow
Oct 06Here's Why We're Not Too Worried About Entera Bio's (NASDAQ:ENTX) Cash Burn Situation
Jun 19Entera Bio secures European patent for oral PTH formulations
Jun 17We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
Mar 20Here's Why Entera Bio (NASDAQ:ENTX) Must Use Its Cash Wisely
Dec 05
Entera Bio EPS misses by $0.22
Nov 19業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2025 | N/A | -28 | N/A | N/A | 1 |
| 12/31/2024 | 0 | -9 | N/A | N/A | 1 |
| 6/30/2024 | 0 | -9 | -7 | -7 | N/A |
| 3/31/2024 | N/A | -9 | -8 | -8 | N/A |
| 12/31/2023 | N/A | -9 | -7 | -7 | N/A |
| 9/30/2023 | 0 | -10 | -7 | -7 | N/A |
| 6/30/2023 | 0 | -11 | -8 | -8 | N/A |
| 3/31/2023 | 0 | -11 | -9 | -9 | N/A |
| 12/31/2022 | 0 | -13 | -13 | -12 | N/A |
| 9/30/2022 | 0 | -14 | -13 | -13 | N/A |
| 6/30/2022 | 0 | -14 | -12 | -12 | N/A |
| 3/31/2022 | 0 | -14 | -12 | -12 | N/A |
| 12/31/2021 | 1 | -12 | -9 | -9 | N/A |
| 9/30/2021 | 1 | -12 | -8 | -8 | N/A |
| 6/30/2021 | 1 | -10 | -9 | -9 | N/A |
| 3/31/2021 | 0 | -11 | -10 | -10 | N/A |
| 12/31/2020 | 0 | -11 | -11 | -11 | N/A |
| 9/30/2020 | 0 | -11 | -12 | -12 | N/A |
| 6/30/2020 | 0 | -13 | -11 | -11 | N/A |
| 3/31/2020 | 0 | -11 | -10 | -10 | N/A |
| 12/31/2019 | 0 | -11 | -9 | -9 | N/A |
| 9/30/2019 | 1 | -10 | -8 | -8 | N/A |
| 6/30/2019 | 1 | -12 | -9 | -9 | N/A |
| 3/31/2019 | 1 | -9 | -9 | -9 | N/A |
| 12/31/2018 | 1 | -10 | -10 | -10 | N/A |
| 9/30/2018 | N/A | -11 | -9 | -9 | N/A |
| 6/30/2018 | N/A | -10 | -8 | -8 | N/A |
| 3/31/2018 | N/A | -13 | N/A | -6 | N/A |
| 12/31/2017 | N/A | -11 | N/A | -5 | N/A |
| 9/30/2017 | N/A | -8 | N/A | -4 | N/A |
| 6/30/2017 | N/A | -6 | N/A | -4 | N/A |
| 3/31/2017 | N/A | -4 | N/A | -4 | N/A |
| 12/31/2016 | N/A | -1 | N/A | -3 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: ENTX is forecast to remain unprofitable over the next 3 years.
収益対市場: ENTX is forecast to remain unprofitable over the next 3 years.
高成長収益: ENTX is forecast to remain unprofitable over the next 3 years.
収益対市場: ENTX's revenue is expected to decline over the next 3 years (-80.3% per year).
高い収益成長: ENTX's revenue is forecast to decline over the next 3 years (-80.3% per year).
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: Insufficient data to determine if ENTX's Return on Equity is forecast to be high in 3 years time